Hepatitis C Drug
-
{
- All
- News
- Videos
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
Hepatitis C Drugs May Help Fight COVID-19, Suggests Study
Several drugs approved for the treatment of hepatitis C viral infection have been identified as potential candidates against COVID-19 caused by the SARS-CoV-2 coronavirus, according to a study based on extensive calculations using supercomputer simulations.
-
India May Soon Get Treatment For Hepatitis C
A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.
-
India May Soon Get Treatment For Hepatitis C
A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.
-
How an $84,000 Drug Got Its Price: 'Let's Hold our Position... Whatever the Headlines'
Gilead Sciences executives were acutely aware in 2013 that their plan to charge an exorbitantly high price for a powerful new hepatitis C drug would spark public outrage, but they pursued the profit-driven strategy anyway, according to a Senate Finance Committee investigation report released Tuesday.
-
Report: US Drug Maker Was Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, US Senate investigators said Tuesday.
-
Report: US Drug Maker Was Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, US Senate investigators said Tuesday.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
Hepatitis C Drugs May Help Fight COVID-19, Suggests Study
Several drugs approved for the treatment of hepatitis C viral infection have been identified as potential candidates against COVID-19 caused by the SARS-CoV-2 coronavirus, according to a study based on extensive calculations using supercomputer simulations.
-
India May Soon Get Treatment For Hepatitis C
A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.
-
India May Soon Get Treatment For Hepatitis C
A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.
-
How an $84,000 Drug Got Its Price: 'Let's Hold our Position... Whatever the Headlines'
Gilead Sciences executives were acutely aware in 2013 that their plan to charge an exorbitantly high price for a powerful new hepatitis C drug would spark public outrage, but they pursued the profit-driven strategy anyway, according to a Senate Finance Committee investigation report released Tuesday.
-
Report: US Drug Maker Was Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, US Senate investigators said Tuesday.
-
Report: US Drug Maker Was Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, US Senate investigators said Tuesday.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
